Rheumatic Complications of Immune Checkpoint Inhibitors.

Immune checkpoint inhibitors activate the immune system to combat cancer. In doing so, however, they can cause immune-related adverse events (irAEs), including rheumatic syndromes, such as inflammatory arthritis, polymyalgia rheumatica, and myositis. This article reviews rheumatic irAEs that may be encountered in the general medicine practice and provides guidance to support prompt recognition, referral, and treatment of these patients.
Competing Interests: Disclosure The authors have no commercial or financial conflicts of interest. N. Ghosh is supported by an NIH grant as a Master’s degree student in Clinical and Translational Investigation at Weill Cornell Medicine: NIH/NCATSUL1-TR-0023849.
(Copyright © 2022 Elsevier Inc. All rights reserved.)